The Patent Finder

Somalogic, Inc.

2 patents currently held · Updated Nov 21, 2026
53 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

Recorded as renamed to Somalogic Operating Co., Inc. (2022)

0
Ending by 2030
Dec 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Oct 14, 2027
    The maintenance fee for Aptamers and diagnostic methods for detecting the EGF receptor (US 10,620,210) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 2 of 2

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,651,556Aptamers and diagnostic methods for detecting the EGF receptor
In force
 · USPTO record
In forceUSPTO record
US 10,620,210Aptamers and diagnostic methods for detecting the EGF receptor
In force
 · USPTO record
In forceUSPTO record
Also on record, not counted in the 2: 53 patents in force now held by others · 13 lapsed for an unpaid fee · 20 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 19 abandoned · 30 no status recorded

Showing 1 to 10 of 53, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
17/480,698Lung Cancer Biomarkers and Uses ThereofSep 21, 2021Pending
17/358,186Jun 25, 2021No status recorded
17/217,006Mar 30, 2021No status recorded
17/438,120Reducing Intersample Analyte Variability in Complex Biological MatricesMar 20, 2020Abandoned
16/751,102Jan 23, 2020No status recorded
17/297,669Methods For Determining Disease Risk Combining Downsampling of Class-Imbalanced Sets With Survival AnalysisNov 21, 2019Pending
17/287,959Methods for Sample Quality AssessmentOct 28, 2019Pending
17/284,556Oct 15, 2019No status recorded
16/973,734Improved Proteomic Multiplex AssaysJun 19, 2019Pending
16/413,989May 16, 2019No status recorded
10 of 53 applications shown.
Pro members see all 53 published applications.
Pro members: see all 53 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited